Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 3/20 | 0.51 |
| ▸ | PARP1 | P09874 | 3/20 | 0.49 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.48 |
| ▸ | CCR2 | P41597 | 6/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | CACNA1H | O95180 | 4/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1359506 | 0.87 | CCR2 (0.47) | PTGESPARP1CHEK1CCR2CACNA1H | |
| SCHEMBL3367539 | 0.86 | CCR2 (0.46) | PTGESPARP1CHEK1CCR2CACNA1H | |
| Lithium Ion SCHEMBL3367542 | 0.85 | CHEK1 (0.44) | PTGESPARP1CHEK1CCR2CACNA1H | |
| SCHEMBL3372968 | 0.82 | CHEK1 (0.70) | PTGESPARP1CHEK1CCR2KDM4E | |
| SCHEMBL16176683 | 0.78 | CACNA1B (0.54) | PTGESCCR2CACNA1HCACNA1BKDM4E | |
| SCHEMBL4064263 | 0.78 | CACNA1H (0.43) | PARP1CACNA1HCACNA1B | |
| SCHEMBL14529004 | 0.78 | MAOB (0.43) | PTGESPARP1MAOBCACNA1HKDM4E | |
| SCHEMBL1360362 | 0.75 | CCR2 (0.52) | PTGESPARP1CCR2CACNA1H | |
| SCHEMBL21200019 | 0.74 | KDM4E (0.52) | PARP1KDM4EHPGD | |
| SCHEMBL19494475 | 0.73 | CACNA1H (0.46) | PTGESPARP1CCR2CACNA1HCACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007053498-A1 | COMPOUNDS USEFUL AS ANTAGONISTS OF CCR2 | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007053499-A2 | COMPOUNDS USEFUL AS ANTAGONISTS OF CCR2 | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-05-10 | — | — | WO | disclosed |